Matches in Nanopublications for { ?s ?p "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP889484.RAolBFEy0QPEKVRk7KLQvs47v7KfMfEVB183sKuGZyykA130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889484.RAolBFEy0QPEKVRk7KLQvs47v7KfMfEVB183sKuGZyykA130_provenance.
- NP652450.RAsoDfhugSGy1z21Obf7md5PQRE3Rkh2vLsahsuySsmMI130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652450.RAsoDfhugSGy1z21Obf7md5PQRE3Rkh2vLsahsuySsmMI130_provenance.
- NP408245.RABuLk-k2_wIw79O781MplEfRe3lC7YuPVJFSokBklAXg130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408245.RABuLk-k2_wIw79O781MplEfRe3lC7YuPVJFSokBklAXg130_provenance.
- NP714067.RAC8OknhOOzcCQJlaslpMwvn988NrtyxcO7yzc6BQtoZw130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714067.RAC8OknhOOzcCQJlaslpMwvn988NrtyxcO7yzc6BQtoZw130_provenance.
- NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP459346.RAgXINAYF0DtItDktWz0mc4aSBkfS1Ze94yKan-Aje1PQ130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459346.RAgXINAYF0DtItDktWz0mc4aSBkfS1Ze94yKan-Aje1PQ130_provenance.
- NP714068.RAM0mFO58ncP9N240V7Jze-2ALwc0vUA30N06bMamFSMc130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714068.RAM0mFO58ncP9N240V7Jze-2ALwc0vUA30N06bMamFSMc130_provenance.
- NP714070.RAPLFeFFgtj6ACcTIaLxtg10eHhBnHSjXF5Oomt-RqkWY130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714070.RAPLFeFFgtj6ACcTIaLxtg10eHhBnHSjXF5Oomt-RqkWY130_provenance.
- NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408296.RAhThBRV3D4CZ5v9Q9Skdbng4vv-QSuJGXcPxTeP1Ar3E130_provenance.
- NP714071.RAq1dwhlPcIOeLOUpTjyK968ODzZUFi73-ZdyXdjb3sHo130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714071.RAq1dwhlPcIOeLOUpTjyK968ODzZUFi73-ZdyXdjb3sHo130_provenance.